Population Pharmacokinetics of Risankizumab in Healthy Volunteers and Subjects with Moderate to Severe Plaque Psoriasis: Integrated Analyses of Phase I–III Clinical Trials - Suleiman, Ahmed A.; Minocha, Mukul; Khatri, Amit; Pang, Yinuo; Othman, Ahmed A. (Clinical pharmacokinetics, 2019)
Keywords: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal - blood; Antibodies, Monoclonal - pharmacokinetics; Bioavailability; C-Reactive Protein - analysis; Clinical trials; Creatinine - blood; Cytokines; Datasets; Drug dosages; Female; Healthy Volunteers; Humans; Injections, Subcutaneous; Internal Medicine; Male; Medicine; Medicine & Public Health; Middle Aged; Models, Biological; Monoclonal antibodies; Original; Original Research Article; Pharmacokinetics; Pharmacology/Toxicology; Pharmacotherapy; Plasma; Population; Psoriasis; Psoriasis - blood; Psoriasis - metabolism; Serum Albumin, Human - analysis; Young Adult; United States--US